Clotting time: Difference between revisions
CSV import |
CSV import |
||
| Line 41: | Line 41: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Medical tests]] | [[Category:Medical tests]] | ||
{{No image}} | |||
Revision as of 10:51, 10 February 2025
Clotting Time
Clotting time is a medical test that measures the time it takes for blood to form a clot. This test is crucial in assessing the blood's ability to coagulate, which is essential for stopping bleeding and initiating wound healing. Clotting time is an important parameter in diagnosing bleeding disorders and monitoring anticoagulant therapy.
Physiology of Blood Clotting
Blood clotting, or coagulation, is a complex process involving a series of steps that lead to the formation of a stable blood clot. This process is initiated when blood vessels are injured, exposing collagen and tissue factor, which activate platelets and the coagulation cascade.
The coagulation cascade consists of two pathways:
- The intrinsic pathway, which is activated by trauma inside the vascular system and is triggered by platelets, exposed endothelium, chemicals, or collagen.
- The extrinsic pathway, which is activated by external trauma that causes blood to escape from the vascular system; this pathway is quicker than the intrinsic pathway.
Both pathways converge into the common pathway, leading to the conversion of prothrombin to thrombin, which then converts fibrinogen to fibrin, forming a stable clot.
Measurement of Clotting Time
Clotting time can be measured using several methods, including:
- The Lee-White method, which involves collecting blood in a glass tube and timing how long it takes to clot.
- The capillary tube method, where blood is collected in a capillary tube and the time taken for the blood to clot is measured.
These methods are less commonly used today, as more precise tests like the Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) are available.
Clinical Significance
Abnormal clotting time can indicate various medical conditions:
- Prolonged clotting time may suggest bleeding disorders such as hemophilia, von Willebrand disease, or liver disease.
- Shortened clotting time can occur in conditions with increased clotting activity, such as disseminated intravascular coagulation (DIC) or thrombophilia.
Monitoring clotting time is also essential in patients receiving anticoagulant therapy, such as warfarin or heparin, to ensure therapeutic levels are maintained without causing excessive bleeding.
Also see
| Clinical biochemistry blood tests (CPT 82000–84999) | ||||||||
|---|---|---|---|---|---|---|---|---|
|